NEWS

META Nominates MP-5342 as First Pre-clinical Candidate for Inflammatory Bowel Disease 2025/10/15

The first candidate molecule derived from the innovative immunometabolism platform has completed preclinical development and is approaching the IND-enabling study stage.

Progress 2025.10.15

All General Progress Spotlight Honor Care

FDA Grants RPDD to META Pharmaceuticals

Progress

2025.08.05

FDA Grants ODD to META-001-PH

Progress

2024.08.23

NEWS

META Nominates MP-5342 as First Pre-clinical Candidate for Inflammatory Bowel Disease 2025/10/15

FDA Grants RPDD to META Pharmaceuticals

FDA Grants ODD to META-001-PH

Discovery Begins Asking How Life Works